
Cannabis use and somatic consequences. Cannabis is the most frequently used illicit psychoactive substance in the world. It is perceived as a low-risk drug, as it is a plant, although many warnings in the medical literature underlined increased complications of cannabis use. Acute and chronic cannabis use is known to be harmful inducing psychiatric and addictive effects. An increase in the potency of cannabis as defined by a high ratio between the more important components, tetrahydrocannabinol and cannabidiol has been observed for years, which leads to more serious complications. Evidence indicates that both acute and chronic consumptions of cannabis can be detrimental to both mental and physical health. Effects of cannabis use include mood disorders, exacerbation of psychotic disorders in vulnerable people, cannabis use disorders, withdrawal syndrome, neurocognitive impairments, cardiovascular and respiratory and other diseases. Synthetic cannabinoid has rapidly spread for the last few years; they are chemical substances inducing similar psychoactive effects to cannabis. Although, cannabis users call these substances "cannabis", synthetic cannabinoids have different pharmacological properties, which make them dangerous substances leading to more serious complications. Physicians dealing with cannabis users should be aware of these differences between vegetal cannabis and synthetic cannabinoids.
Complications somatiques du cannabis. Le cannabis reste la substance illicite la plus consommée dans le monde. La perception du cannabis comme une substance peu dangereuse au regard de son origine végétale participe à l’augmentation de son usage. La puissance du cannabis est définie par un ratio élevé entre les composants les plus importants du cannabis, c’est-à-dire letétrahydrocannabinol et le cannabidiol. Les effets aigus et chroniques de l’usage du cannabis comportent un risque majoré de troubles psychiatriques, mais aussi de complications cardiovasculaires, neurovasculaires et neurocognitives, respiratoires et de sevrage en cas de dépendance. Avec l’apparition récente des cannabinoïdes de synthèse qui sont des substances chimiques contrairement au cannabis issu de la plante, des complications plus sévères sont décrites même lors d’usage unique. Ces nouvelles substances de synthèse, bien qu’appelées aussi cannabis par les utilisateurs, ont conduit à une modification des prises en charge des usagers en raison d’une toxicité aiguë et chronique plus sévère.
Behavior, Addictive, Analgesics, Substance-Related Disorders, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, Cannabinoids, Humans, Dronabinol, Cannabis
Behavior, Addictive, Analgesics, Substance-Related Disorders, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, Cannabinoids, Humans, Dronabinol, Cannabis
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
